71837-1000 BIZENGRI - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

71837-1000

Brand Name:

BIZENGRI

Generic Name:

Zenocutuzumab

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: ZENOCUTUZUMAB

Strength: 20.0

Unit: mg/mL

Packages:

Code: 71837-1000-02

Description: 2 VIAL, GLASS in 1 CARTON (71837-1000-2) / 18.75 mL in 1 VIAL, GLASS (71837-1000-1)

Effective Date: Dec. 16, 2024

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Bispecific Antibody

Minor Class:

HER2, HER3

Orphan Drug Designation:

Yes

Status:

In Use